BE719631A - - Google Patents
Info
- Publication number
- BE719631A BE719631A BE719631DA BE719631A BE 719631 A BE719631 A BE 719631A BE 719631D A BE719631D A BE 719631DA BE 719631 A BE719631 A BE 719631A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH197668A CH498122A (de) | 1968-02-09 | 1968-02-09 | Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE719631A true BE719631A (fr) | 1969-02-17 |
Family
ID=4223010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE719631D BE719631A (fr) | 1968-02-09 | 1968-08-16 |
Country Status (10)
| Country | Link |
|---|---|
| AT (1) | AT277257B (fr) |
| BE (1) | BE719631A (fr) |
| CH (1) | CH498122A (fr) |
| DE (1) | DE1795132A1 (fr) |
| DK (1) | DK123526B (fr) |
| ES (1) | ES357247A1 (fr) |
| FR (1) | FR1598948A (fr) |
| GB (1) | GB1225053A (fr) |
| IL (1) | IL30458A (fr) |
| NL (1) | NL6811311A (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2207430C3 (de) * | 1972-02-14 | 1982-05-13 | Pennwalt Corp., 19102 Philadelphia, Pa. | 1,2,4,5-Tetrahydro-3H-3-benzazepin, ein Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel |
| US4197297A (en) * | 1976-11-17 | 1980-04-08 | Smithkline Corporation | 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4160765A (en) * | 1976-11-17 | 1979-07-10 | Smithkline Corporation | Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| US4171359A (en) * | 1978-04-12 | 1979-10-16 | Smithkline Corporation | Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| PL2332921T3 (pl) | 2003-06-17 | 2016-08-31 | Arena Pharm Inc | Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
| AU2004253888B2 (en) | 2003-06-17 | 2010-11-11 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| TW200510324A (en) * | 2003-08-11 | 2005-03-16 | Lilly Co Eli | 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| PT1838677E (pt) | 2004-12-21 | 2009-11-16 | Arena Pharm Inc | Formas cristalinas do cloridrato de (r)-8-cloro-1-metil- 2,3,4,5-tetra-hidro-1h-3-benzazepina |
| DE602005016601D1 (de) | 2004-12-23 | 2009-10-22 | Arena Pharm Inc | 5ht2c-rezeptor-modulator-zusammensetzungen und anwendungsverfahren |
| US8168782B2 (en) | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
| CN101547892B (zh) | 2006-12-05 | 2014-08-20 | 艾尼纳制药公司 | 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体 |
| CN102015591B (zh) | 2008-03-04 | 2014-01-29 | 艾尼纳制药公司 | 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法 |
| US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| JP2013539470A (ja) | 2010-09-01 | 2013-10-24 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ロルカセリンと光学活性な酸との塩 |
| KR20130101524A (ko) | 2010-09-01 | 2013-09-13 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 아고니스트의 비-흡습성 염 |
| NZ608266A (en) | 2010-09-01 | 2015-09-25 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
| EP2611427B1 (fr) | 2010-09-01 | 2018-10-17 | Arena Pharmaceuticals, Inc. | Formes galéniques à libération modifiée d'agonistes de 5-ht2c, utiles pour la gestion du poids |
| KR20150070249A (ko) | 2012-10-09 | 2015-06-24 | 아레나 파마슈티칼스, 인크. | 체중 관리 방법 |
-
1968
- 1968-02-09 CH CH197668A patent/CH498122A/de not_active IP Right Cessation
- 1968-07-29 IL IL30458A patent/IL30458A/en unknown
- 1968-08-08 DK DK383268AA patent/DK123526B/da unknown
- 1968-08-08 NL NL6811311A patent/NL6811311A/xx unknown
- 1968-08-14 GB GB38772/68A patent/GB1225053A/en not_active Expired
- 1968-08-14 ES ES357247A patent/ES357247A1/es not_active Expired
- 1968-08-14 DE DE19681795132 patent/DE1795132A1/de active Pending
- 1968-08-14 AT AT797568A patent/AT277257B/de not_active IP Right Cessation
- 1968-08-14 FR FR1598948D patent/FR1598948A/fr not_active Expired
- 1968-08-16 BE BE719631D patent/BE719631A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK123526B (da) | 1972-07-03 |
| FR1598948A (fr) | 1970-07-15 |
| IL30458A (en) | 1972-03-28 |
| DE1795132A1 (de) | 1972-01-05 |
| CH498122A (de) | 1970-10-31 |
| IL30458A0 (en) | 1968-09-26 |
| NL6811311A (fr) | 1969-08-12 |
| ES357247A1 (es) | 1970-03-01 |
| AT277257B (de) | 1969-12-29 |
| GB1225053A (en) | 1971-03-17 |